THEBIOMEDICALSCIENTIST.NET THE
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/4e37cd97bdd9c55c977001d961e3d098.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/2d540c4f12d4437de50a0ec5035cdf95.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/b7754a90bbdc66c6b541249f45e01e5a.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/3e071b81c5619ce3736bfb64b48ed767.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/be9087a50145eaa7af528572612156a8.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/44d99524d6c315c249e18284671d2ea0.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/8eeab72c61aae5e1f50dfe05b07b8db8.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/0f520b8a776a813756843c97aac80c10.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/4587f47e26ba215276019e3813f09e88.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/1e28435b8d066528d6db9cb9a894af01.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/f18560d5a667ae30e4a5f63564b2610d.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/2530ca9115a9305762647a3a2cba40d1.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/f822cfbc729c0f15dc6480db5f57b14a.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/a8de4e701f457caeac293c6b6f21bb77.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/27b51f5756319335ba4e9cdb39ed6439.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/1515a0d2622d23f28a301dc9c7c09c75.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/e056c8341e8277a9c06e43940861c5bc.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/155c35d7ca2a495f34deebe544ed4f22.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/28ba6ff1e8ab50c1d6624f33a587e575.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/a6547d955096b9c216d8369c3a94efe4.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/95b82a59ac2ed3c01e0429e2fb4c0635.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/ac21fc64b714add4412016b661065719.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/4802baadbf7eee28df9f75d43912bb31.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/26b8b28569bcd8bfa1760a65e838f856.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/65c3c064e2b35386ba0f80fc8d4a4566.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/a879cc79281f13df3dd69d740e8f3792.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/bc770a496d69753fadea14710ce2714a.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/cacf0546f95ddea8922384de86898562.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/6266080d0cb3b2175c2f2cf6c24caf27.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/1cc5070fd2aedbda97aab3464197a020.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/ee61c55c78fdd19d8dfdddc20de97365.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/45cd33ce90d8992561e31131ecaf0b27.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/2e81977fceb0cbd4fd74ac76ea30f141.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/ccf422e4d30ff647ede982245f1eb54a.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/b92e7ef4c33f19e2ef20fdcc92a959e7.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/4f9a16177240159d1b56902a2fa7a12b.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/83baeac1f360ae346f7a2a49352288a2.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/fa8ee80c28bc265b6a443093fcb9a8cb.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/6dd1ce776a81b7c6963c8e8cb1bff39d.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/ee1ba8a54d782c15e89bf5a154b054b5.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/2f7f3db1754cbb21c142572e8aa59c12.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/0a71007d73ab4b096d5018f944150fa2.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/b9deb59e679cc475bdd2aeecc8107257.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/df09293934bb7a0576073423e11e824f.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/eb4752492c9b7fae7355e2c11240617e.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/a0b7e9e9a236843dda76a4e82616d83b.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/61a4a1f76456e6dd2d18387379c38dee.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/d57be738df2a072ce1b2fb612c146a02.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/67ca48ce62b2d756375fe3177e844d77.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/d66dd1b62e43d321688a51c79a4e4835.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/c4720ef04c641b912ea98ea97834cf54.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/47d8400c30f79d0d0c945959f4dc7d3b.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/5e55bbcc4d4e4422cf79f3146fb52cd2.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/0cd97aa0f84711aad609ee1de249392a.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/cc5c437866bc630b0b70044e67247f3d.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/21f4a211fa2c6978fbd57d7ff1a02db1.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/473e14dbedb1f523ff21eac0aa27535a.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/7774b63514792d81e71bcd9aef08bfaa.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/7c38fe3f56a5ccc0067db9079db92a9c.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/ca3580abdda5a1e66166ab1cf1aaa747.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/a03d727642648cc418f5108184e67689.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/8c0bff4d20fae07622a504789303632f.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/f89f62d9d69b61104ff42fcf561f4a5a.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/dda942331037ec118dd01f81bf75f9b7.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/05265a9b9a8ded485ff42bd289131f28.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/b43e1952ac22ff8760176543227765b1.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/8642c5087b7e99756c9bb642c9a475f2.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/8957b5b473f612a04104d5111e5a94cd.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/47a633d6e515f4a38869d55e45bb62f7.jpeg)
![](https://assets.isu.pub/document-structure/240411094350-1cbdc1765881f3a10425971b9efb8eb8/v1/a1add83bc78b3986eb472d84a7b6c363.jpeg)
At the IBMS, we understand the critical role suppliers play in supporting you to provide better patient care.
This guide aims to help you navigate a dynamic professional landscape and find the products, services and expertise your laboratory needs.
In 2024, pathology services continue to evolve rapidly. New regulations, ongoing advancements in technology and the evolving postpandemic environment continue to challenge and excite. This year’s guide reflects these changes, with updated information and resources to help you reach the right people.
The 2023 IBMS Congress was a resounding success, fostering valuable connections and showcasing the latest offerings from our industry partners. The exhibition provided a well-needed platform for our suppliers to demonstrate their
innovations and engage with our professional community.
The biggest event of its kind by far, the reach and positive impact of Congress on patient care is felt long after the closing plenary – through the relationships it helps to build.
The IBMS is advocating for our members on a scale never seen before, engaging with healthcare providers, regulatory bodies and industry associations, and collaborating with government and industry leaders.
In September 2023, we
worked with Microsoft to produce a white paper, Digital Pathology and Integrated Care Systems, hoping to motivate advances that will reduce costs, increase efficiency and improve patient care. In January 2024, we worked with AstraZeneca to publish Time to Test – a paper on how to create the capacity the NHS needs for the future of cancer testing (see p.14).
As the IBMS’ reach and impact grow, we are striving to create an environment where both our members and their suppliers can thrive and contribute to a forwardthinking UK diagnostics sector.
This guide is your vital connection to the individuals and teams shaping the future of healthcare. Utilise the updated contact information, explore company profiles and discover new opportunities for collaboration. Remember, every interaction you have can contribute to improved patient care. Together, we can make a real difference. BMS
Last year the IBMS published the Long Term Biomedical Scientist Workforce Plan. It presents a bold strategy for the UK to develop the biomedical scientist workforce to operate at the highest levels of practice.
Following are some of the striking statistics from the document.
1960
Biomedical scientists are one of the longest established regulated healthcare professions, having been regulated by statute since 1960.
27, 00014 , 000
They also form the largest professional group within healthcare science (40%) and account for more than 27,000 of the Health and Care Professions Council (HCPC) registrants.
Biomedical scientists are the largest staff group in UK pathology labs at approximately 14,000.
UP TO 360,000 STAFF SHORT
In 2017, Health Education England predicted that if demand-led growth for healthcare remained constant, 190,000 new healthcare posts would be needed by 2027. Fast-forward to 2023 and the NHS England Long Term Workforce Plan predicts a shortfall of between 260,000 and 360,000 staff by 2036/37.
3% OF HISTOPATHOLOGY DEPARTMENTS
Only 3% of histopathology departments that responded to a survey said they had enough staff to meet clinical demand. The Royal College of Pathologists (RCPath) survey also revealed that a quarter of all histopathologists are aged 55 or over
40% INCREASE
Cancer Research UK estimates that, with a growing and ageing population, the projected increase in the number of cancer cases will be more than 40% above current levels – to about 514,000 new cases per year in 2035. The statement comes from Testing times to come? An evaluation of pathology capacity in England.
Of the departments who responded to the RCPath survey questions on costs, around £9.8m a year is spent on locums, covering 77 posts at an annual average of £127,000 each.
If this figure was extrapolated to cover the UK, it would equate to around £17m.
The IBMS issues more than 1000 Certificates of Competence each year to biomedical science graduates from IBMS Accredited biomedical science degrees who have completed their pre-registration training in an IBMS-approved training laboratory.
Training biomedical scientists and clinical scientists to undertake selected histopathology reporting through IBMS qualifications is financially highly efficient.
£2000 The examination costs for a scientist to complete the four-year training programme to report the full spectrum of gastrointestinal or gynaecological samples is less than £2000
£1000 For a scientist to qualify to report bowel and cervical screening biopsies alone it takes approximately eighteen months with examination costs of less than £1000.
In 1992, the IBMS launched the Company Membership scheme and the Company Members Liaison Group, which comprised Company Members and Institute Officers. The latter held its first meeting in 1992, which provided an excellent forum to discuss issues at the Liverpool Triennial and work with exhibitors to transform the event.
Fast-forward to the present and the scheme connects a members’ network of over 20,000 biomedical staff worldwide to many of the leading organisations in biomedical science, covering disciplines across the sector.
One of the Institute’s central aims for the scheme is to ensure that members are up to date with the latest developments in technology and advances in scientific techniques.
Working with the Company Members also enables the delivery of the highly successful annual Congress, while the companies also support local IBMS regional and branch scientific events and recognise members’ achievements through the award of the Company Members Prize, which is presented to the IBMS member who achieves the highest mark in each specialist
James WebberBD Current members of the IBMS Company Members Committee
Mark Reed (Chair)Pro-Lab Diagnostics
Lesley Ayres (Secretary)TCS Biosciences
Leanne AnnereauStago UK
Michelle ColemanSynnovis
David CarterVector Labs
Helen TuckerThermo Fisher
subject of the Higher Specialist Diploma examination.
The IBMS Company Members Committee (see box) works closely with IBMS committees and staff to help organise Congress and strengthen links between biomedical science companies and IBMS members.
Mark Reed, IBMS Company Members Committee Chairman, says: “Open-forum communication between all aspects of the industry, trade association, professional body and working parties is essential for the future of all in this continually changing and challenging business. The partnership between the IBMS and its Company Members continues to be extremely important.”
For more information, email mc@ibms.org BMS
Point-of-care testing (POCT) services are growing fast. To meet the challenge a suitable workforce with technical, operational and clinical skills is required. This would support the ongoing governance of services and ensure that tests of the appropriate quality are effectively deployed for a positive impact on existing and new patient pathways. Service
providers need to be agile, quick to respond to clinical need and have connections within the organisation that allow rapid evaluation and approval of the clinical and operational need for a new device or test.
To maintain current resources and deliver the workforce of the future, teams need to understand the mechanism of growing the establishment, funding streams and the process of
Tony Cambridge, a Lead Biomedical Scientist working across blood sciences and Point-of-Care Testing, looks at the trends in the sector.approval for growth. This can be achieved by in-year business cases that address a specific challenge or form the part of a larger case that describes the projected need based on how developments in healthcare are dictating the support required.
There is no specific national job profile for any POCT role. Individual job descriptions and person specifications need to be written for roles in POCT and there are some excellent examples in use. I feel there is a need to now recognise POCT as a standalone specialty within biomedical science. It is unlikely that specific degrees will be tailored to POCT, but the existing biomedical science degrees would do well to incorporate an increasing level of POCT knowledge.
There are supplementary studies that graduates can undertake, including the IBMS Certificate of Expert Practice (CEP) in Point of Care. However, it is difficult to formalise the requirements for additional qualifications, knowledge and experience in current job descriptions. Many graduating biomedical scientists would not have been exposed to these services and will directly enter a recognised specialism of biomedical science.
This is one problem with recruiting to posts in POCT unless those scientists rotate through the POCT service as part of their local training.
The IBMS is reviewing the biomedical sciences portfolios, which may deliver a boost to the future workforce.
Innovations in technology
Techniques and methodologies in use across the rapid diagnostics landscape have evolved quickly in recent years with a surge in qualitative and quantitative lateral flow devices to molecular diagnostics. Sensor technology employed in analytical devices or those worn by patients have become more precise and less susceptible to interfering substances. Miniaturisation of analytics continues, with more microfluidic solutions coming to market, covering an impressive repertoire of tests. The multi-analyte device is becoming ever more popular, using the same pre-analytical and analytical processes for a range of tests, reducing the
different devices required to achieve the same panel of tests. Multiplex testing is proving popular, supporting clinical suspicion, and reducing time to clinical decision by analysing a wide range of targets in the same testing phase. Computer-assisted learning and artificial intelligence continue to make an impact on healthcare. Large datasets are being used to develop new algorithms to drive clinical decision support software, improving efficiency and standardising care. They remain essential to bring us a step closer to precision and personalised medicine, although care decisions must not be taken out of the qualified clinician’s hands.
The pathology networks set up through NHS England and NHS Improvement continue to mature, sights firmly set on
removing unwarranted variation in service delivery through the GIRFT (Get It Right First Time) agenda, collaborative working and improved consolidation.
The delivery of the NHS Long Term Plan depends, in part, on effective primary care networks, urgent treatment and diagnostic centres, same-day emergency care and expansion of virtual wards and hospital-at-home activities.
The creation of optimisation groups has led to an improved understanding of which test should be offered where and to whom, to have the maximum benefit on healthcare delivery. Community diagnostics centres are being designed to address backlogs in imaging and associated diagnostics and provide improved access for patients, avoiding hospital attendance. Improved diagnostic capabilities of urgent treatment centres is also supporting emergency services by managing specific cases away from emergency departments
Community, high street and at-home diagnostics
Diagnostics are more accessible than ever. There is certainly plenty of evidence to suggest that patients cared for in their own homes have faster recovery times and less risk than those recovering in hospital, if well enough to do so. Where necessary,
“Techniques and methodologies in use across the rapid diagnostics landscape have evolved quickly in recent years”
patients can now be sent home with diagnostic devices and tablets that allow for results to be submitted for review by a supervising clinician. The high street has also become a convenient source of diagnostic testing and consultations, with pharmacies keen to improve the range of services they can offer the public. A wide range of tests have now made their way into the public domain and in recent times it has become possible to order tests online or purchase in the supermarket, even the fuel station. The validity of these tests and the governance surrounding their provision is unknown to the author and cannot be commented on further. However, they are becoming more popular among a curious public who are taking more control over their own health and wellbeing.
I am a huge advocate for rapid diagnostics, if provided with excellent governance and patient safety remains the priority.
I’ve been providing POCT events twice a year since 2018 through
Thornhill Healthcare Events Ltd, along with consultancy and the POCTInnovators.com website, which champions the use of medical devices across multiple healthcare delivery points.
These events provide opportunities to share best practice, experience and knowledge. To ensure the events are accessible to the widest audience they are often offered free to the NHS, and from 2024 they are offered free to those in academia.
Although I work full-time in the NHS as well as providing events and consultancy, I am also a member of a BIVDA steering group, a tutor for the IBMS Certificate of Expert Practice in POCT, scientific advisory committee member to national and international commercial companies.
I encourage everyone to regularly attend these types of events, ensure your continuing professional development, and contribute to shared learning where you can. Collaborating and sharing is key to success.
For more information visit poctinnovators.com. BMS
Tony Cambridge, Lead Biomedical Scientist , Pathology Management Blood Sciences and Point of Care Testing, University Hospitals Plymouth NHS Trust.
We look at the study that led to the government approving the use of digital pathology for cancer screening.
Following the Government and NHS England backing the UK National Screening Committee recommendation on digital pathology, there is likely to be an increase in the uptake and use of the technology.
Also, earlier this year, Minister of Health and Secondary Care Andrew Stephenson confirmed that NHS England is investing in a digital learning platform to
support the take-up of digital pathology technology in the health service.
The use of digital pathology in cancer screening samples has been embargoed until now, because there was deemed to be insufficient data to support its use in this setting.
Here we look at the National Institute for Health and Care Research (NIHR)funded study that led to the approval of digital pathology use
to help speed up analysis of cancer screening samples.
The research was carried out by University Hospitals Coventry and Warwickshire (UHCW) NHS Trust and The University of Warwick’s Clinical Trials Unit.
Lead Researcher
Consultant Pathologist
Professor David Snead, of UHCW and The University of Warwick, said: “I am delighted that digital pathology is cleared for
use in cancer screening programmes. It is a big milestone to achieve and we are extremely proud that the work we have led proved so effective in making this change.
“The team would like to thank the pathologists, research fellows, statisticians and laboratory technicians who conducted the study and the technical support received from 3DHISTECH and Philips in providing equipment to make it happen. It was a huge task to do, but the data we produced was vital to demonstrate this technology is safe in the hands of our pathologists.’
In total, six NHS hospitals took part in the study: University Hospitals Coventry and Warwickshire; Belfast City Hospital; Nottingham University Hospital; Oxford John Radcliffe Hospital; United Lincolnshire Hospital
“The data we produced was vital to demonstrate this technology is safe in the hands of our pathologists”
and University Hospitals Birmingham.
The study’s aim was to demonstrate equivalence in pathologists’ reporting of a sample when using digital pathology in comparison to light microscopy, the current
A total of cases ( breast, GI, skin, renal) were included in the study. This included breast and bowel cancer screening samples. Cases were examined by four pathologists using both digital pathology and light microscopy. Reports were compared for clinical management concordance (CMC) – identical diagnoses plus differences that do not affect patient management. Percentage CMCs were computed using logistic regression models with crossed random-effects terms for case and pathologist. The obtained percentage CMCs were referenced to .% calculated from previous studies. For all cases, light microscopy versus digital pathology comparisons showed the CMC rates were .%.
standard. Sixteen pathologists took part in the study, four each in four specialities: skin, breast, GI and renal. The pathologists reported on each anonymous sample within their speciality using both digital pathology and light microscopy. In total, 2024 samples were used across all four specialities, and 16,192 reports were created during the study (see box, left, for more details).
The study was funded by the NIHR, Health Technology Assessment Programme and supported by the University of Warwick’s Clinical Trials Unit.
Professor Janet Dunn, lead for the Warwick Clinical Trials Unit, said: “It is great that the UK Government recognises the importance of this research and has approved the use of digital pathology for screening. It was a pleasure to work with Professor David Snead on this important study”.
The paper is entitled “Digital pathology for reporting histopathology samples, including cancer screening samples – definitive evidence from a multisite study” and was published in January in the open-access journal Histopathology. BMS
SIX RECOMMENDATIONS
A paper from the IBMS and AstraZeneca, Time to Test, outlines how to create the capacity the NHS needs for the future of cancer testing.
Grow the workforce
01
The NHS should support pathologists in playing a key role in multidisciplinary teams, and biomedical and clinical scientists in operating at the top of their licence.
02
Bring cancer testing together
Ensure testing is organised according to the needs of patients and multidisciplinary teams, delivering commonly used or established tests closer to patients and at the quality and scale required.
03
Enable providers to deliver
When centralised testing services are unable to provide a timely, high-quality service, other providers should be supported to lend additional capacity, providing the right test at the right time.
04
Improve data
The publication of a genomics informatics implementation plan is a vital step towards improving quality and unlocking capacity.
05
Develop a cancer testing accountability framework
Quality measures should be established, which all NHS cancer testing providers adhere to, with comparable data published on performance.
06
Invest in the fundamentals
Investing in the fundamentals of infrastructure and logistics through increased capital funding would enable services to deliver high-quality tests with rapid turnaround times and support the expansion of services fit for the future.
KEY
CC Clinical chemistry
C Cytopathology
HT Haemotology & transfusion science
H Histopathology
I Immunology
MV Microbiology & virology
MG Molecular pathology & genomics
T:
E: lisa.harrison@abbott.com
W: www.corelaboratory.abbott/int/en/home
Key contact: Judy Barber CC HT
T:
E: ukmarketing@biomerieux.com
W: www.biomerieux.com
Key contact: Lauren Campbell I MV
As a world leader in microbiology for years, bioMérieux is committed to major public health issues in the field of infectious diseases, such as antimicrobial resistance, respiratory infections and sepsis. bioMérieux provides innovative end-to-end diagnostic solutions that improve patient outcomes, help prevent antimicrobial resistance and improve antimicrobial stewardship, as well as empowering clinicians and laboratorians in decision making by providing actionable data through integrated IT and DATA solutions.
T:
E: info@cirdan.com
W: www.cirdan.com
Key contact: Rebecca Fitton H HT
Cirdan is a leading provider of pathology informatics and imaging solutions that support and speed up patient diagnosis. Cirdan is recognised as one of the leading suppliers of laboratory information systems (LIS) worldwide. Our products include ULTRA, a LIS that supports and streamlines clinical laboratory operations, specimen x-ray cabinets which expedite breast cancer diagnosis and Tutor, a digital pathology education platform. With additional solutions that support artificial intelligence and machine learning in digital pathology technologies. Find out more at www.cirdan.com.
T:
E: info-uk@clinisys.com
W: www.clinisys.co.uk
Key contact: Matthew Fouracre H MG
Clinisys is a global provider of intelligent diagnostic informatics solutions and expertise designed to redefine the modern laboratory, across healthcare, life sciences, and public health. Millions of diagnostic results and data insights are generated every day using Clinisys’ solutions in over , laboratories across countries. Our WinPath LIMS is installed in over % of NHS labs across the UK.
Clinisys’ mission is to enhance the effectiveness of diagnostic workflows in any laboratory or testing environment and keep citizens and communities healthier and safer.
T:
E: enquiries@genmed.eu
W: www.genmed.eu
T:
E: euinfo@hologic.com
W: www.hologic.com
Key contact: Fiona Smith MV MG
Hologic is an innovative global medical technology company primarily focused on improving women’s health and well-being and a specialist in high-volume population screening. By providing early and accurate results, our goal is to minimize doubt and maximize the confidence our customers and their patients have in their decisions and diagnoses. For more information visit www.hologic.co.uk.
T:
E: info@intersystems.com
W: www.intersystems.com/uk
T:
E: info@intsoftsol.com
W: www.iss-lims.com
Key contact: Tony Carter
T:
E: support.uk@leicabiosystems.com
W: www.leicabiosystems.com
Key contact: Rachel Aldridge/Lily Kremer H I Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our experts are committed to delivering Improved Quality, Integrated Solutions, and Optimized Efficiencies leading to breakthrough advances in diagnostic confidence. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture.
T:
E: discover.uk@nikon.com
W: www.nikon.co.uk/en_GB
Key contact: Natalia Alexander H MV
Nikon are focused on serving customers in the clinical microscopy field with industry leading solutions. To meet the demands of clinical laboratory specialists and researchers, Nikon provides ergonomic, flexible microscopes with enhanced functionality and ease of use.
Our microscopes are designed to ensure a natural posture is maintained while in use, and our camera systems offer high resolution images that can be easily streamed for the evolving needs of our clinical customers.
T:
E: uk@pfmmedical.com
W: www.pfmmedical.co.uk/products/ histotechnology/
Key contact: Jemma Heath H
T:
E: burgesshill.marketing@roche.com
W: www.diagnostics.roche.com
CC MG
At Roche Diagnostics we believe time is precious and we are dedicated to providing diagnostic tests and services that give people more time with their loved ones. We are proud to be the UK’s leading provider of in vitro diagnostics tests and in more than million Roche diagnostic tests were used by clinicians across the UK to confirm, rule out or manage health conditions including cancer, heart disease, diabetes, COVID-, hepatitis, human papillomavirus (HPV) and many others .
T:
E: enquiries@sourcebioscience.com
W: www.sourcebioscience.com
Key contact: Klaudyna Johnstone I MG
Source LDPath provides an end-to-end clinical healthcare service from histopathology, including digital pathology and AI, through to molecular diagnostics services; bringing a comprehensive workflow for the delivery of pathology diagnostics and precision therapeutics. With market-leading turnaround times, Source LDPath is committed to driving the delivery of precision healthcare.
Offering a unique modular integration model, the company supports the implementation of digital pathology in routine practice, aiding over NHS Trusts and private pathology departments.
KEY
CC Clinical chemistry
C Cytopathology
HT Haemotology & transfusion science
H Histopathology
I Immunology
MV Microbiology & virology
MG Molecular pathology & genomics
ABBOTT DIAGNOSTICS UK
T:
E: lisa.harrison@abbott.com
W: www.corelaboratory.abbott/int/en/home
Key contact: Judy Barber CC HT
AB SCIENTIFIC LTD
T:
E: info@abscientific.com
W: www.abscientific.com
Key contact: Nigel Baron HT MV ADVANCED INSTRUMENTS LTD
T:
E: ukorders@aicompanies.co.uk
W: www.aicompanies.co.uk
Key contact: Jim Smith CC MV
AESKU UK LTD
T:
E: ukcustomerservices@aesku.com
W: www.Aesku.com
Key contact: Anthony Celli I MV
T:
E: customercare_uk@agilent.com
W: www.agilent.com
T:
E: enquiries@menarinidiag.co.uk
W: www.menarinidiag.co.uk
Key contact: Mira Pasanen H MV
A.Menarini Diagnostics is committed to bringing innovative solutions to the clinical diagnostics market, providing healthcare professionals with the best possible solutions for their diagnostics needs and to improve patients’ quality of life. We address laboratory needs for infectious diseases, diabetes management, urinanalysis and haematology. We offer solutions for different laboratories such as biochemistry, microbiology, molecular, point of care and histopathology. In addition, we offer innovative tube labelling solutions for pre-analytics.
T:
E: info@aspectscientific.com
W: www.aspectscientific.com
CC I
Aspect Scientific specialise in ELISA Automation Systems and offer the market leading Dynex Technologies range of instrumentation capable of automating any ELISA assay and any level of workload, from single plates to plates simultaneously. Combining flexible, open and convenient instrumentation with our comprehensive technical service and support to automate your microplate assays.
We also supply the extensive, high-quality range of EKF Stanbio clinical chemistry reagents, which can be automated with many chemistry analysers, including our Altair random access analyser.
T:
E: BDdiagnosticsUKI@bd.com
W: www.bd.com/en-uk MV MG
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com
T:
E: infouk@beckman.com
W: www.beckmancoulter.com
Key contact: Sue Crowe
T:
E: ukmarketing@biomerieux.com
W: www.biomerieux.com
CC HT
Key contact: Lauren Campbell I MV
As a world leader in microbiology for years, bioMérieux is committed to major public health issues in the field of infectious diseases, such as antimicrobial resistance, respiratory infections and sepsis.
bioMérieux provides innovative end-to-end diagnostic solutions that improve patient outcomes, help prevent antimicrobial resistance and improve antimicrobial stewardship, as well as empowering clinicians and laboratorians in decision making by providing actionable data through integrated IT and DATA solutions.
T:
E: Contact_NorthEurope@bio-rad.com
W: www.bio-rad.com
T:
E: sales@cepheideurope.co.uk
W: www.cepheid.com
Key contact: Edward Levitt MV
T: +
E: customercare@copangroup.com
W: www.copangroup.com
Key contact: Alessia Tomasi MV MG
Copan is dedicated to developing high-quality sample collection products for infectious diseases, human genomics, and forensic applications, along with automated workflow solutions. Our ideas drove years of preanalytics progress, resulting in meaningful products tailored to fit any need. Among them, FLOQ technology revolutionized sample collection, while WASPLab® advanced hardware and A.I. modules redefined full lab automation. Copan’s Workflow-Integrated System Environment can accompany biological samples from the collection to impeccable diagnostics, unlocking your lab’s real potential and improving patient care.
T:
E: sales@elitechuk.com
W: www.elitechgroup.com
Key contact: Lee Roberts
T:
E: sales@elkaylabs.com
W: www.elkaylabs.com
Key contact: Robin Conway CC MG
T: + ()
E: sales@eurobio-scientific.co.uk
W: www.eurobio-scientific.co.uk
Key contact: Rob Cordingley HT MG
Eurobio Scientific is a manufacturer and distributor of reagents, controls, calibrators, and instrumentation in the fields of Blood Sciences, Molecular Biology, Life Sciences and Transplantation to Clinical Diagnostic and Research Laboratories.
Eurobio Scientific also operates its online, independent PathQAS Quality Assurance Schemes to help customers comply with ISO :
Product Listing
Haemostasis & Biochemistry - reagents and instruments
Molecular - Extraction and PCR Kits
Immunology QC - Allergy, Autoimmunity
Calprotectin QC
FungiLine
Bone and Cartilage Markers
Diabetes and Obesity Markers
Transplantation
FUJIFILM UK LTD
T: + ()
E: katherine.john@fujifilm.com
W: www.fujimed.co.uk
Key contact: Katherine John CC MV
T:
E: customersupport-uk@gilson.com
W: www.gilson.com
Key contact: Dave Rooks CC MV
We are Gilson, a third-generation family-owned company developing liquid handling, purification and extraction solutions for the life science industry. Since , we have developed innovative products, designed to improve the reproducibility and traceability of data, connecting with the scientific community to help researchers achieve verifiable results. Since the introduction of the high-precision PIPETMAN® pipette, Gilson has revolutionised laboratories, providing a range of quality and innovative solutions including purification systems, solid phase extraction (SPE) systems, automated liquid handlers, pipettes & accessories.
T:
E: ukdiagnostic@grifols.com
W: www.grifols.com
Key contact: Pat Lynch
T:
E: sales@gtvision.co.uk
W: www.gtvision.co.uk
Key contact: Neil Patterson H MV
Established + years, GT Vision Ltd. is a specialist UK-owned microscope company with a wealth of experience and knowledge in microscope sales, installation, training, service and repair.
We are main agents for Leica microscopes and other firmly established brands, and additionally offer our own extensive and more affordable range of microscopes, accessories, cameras and scanning systems.
Our dedicated service and support department offers repairs, plus routine and contract service for almost any make, model and age of microscope.
T:
E: euinfo@hologic.com
W: www.hologic.com
Key contact: Fiona Smith MV MG
Hologic is an innovative global medical technology company primarily focused on improving women’s health and well-being and a specialist in high-volume population screening. By providing early and accurate results, our goal is to minimize doubt and maximize the confidence our customers and their patients have in their decisions and diagnoses. For more information visit www.hologic.co.uk.
T:
E: sales.hduk@horiba.com
W: www.horiba.com/uk
Key contact: Tariq Neiman CC HT
T:
E: raldridge@illumina.com
W: https://emea.illumina.com
Key contact: Rachel Aldridge/Lily Kremer MV MG
Our mission is to improve human health by unlocking the power of the genome. We believe that, together, we can use genomics to build a stronger world for all.
T: + ()
E: uk-sales@immucor.com
W: www.immucor.com
Key contact: Patrick Lynch
Immucor is a global leader of transfusion and transplantation diagnostics. For transfusions, Immucor offers the broadest line of serological products, NEO Iris® and Echo Lumena®, including traditional and unique specialty reagents, Capture® technology and scalable solutions for automating immunohaematology testing. Our BioArray molecular immunohaematology assays provide state-of-the-art technology for pre-transfusion compatibility testing. For transplants, our LIFECODES products and MIA FORA deliver highly accurate testing solutions for donor-patient compatibility. Finally, our specialty diagnostic solutions for platelet testing and haemostasis provide important diagnostic information for today’s modern laboratories.
T:
E: info@intsoftsol.com
W: www.iss-lims.com
Key contact: Tony Carter CC HT
T:
E: enquiries@launchdiagnostics.com
W: www.launchdiagnostics.com
Key contact: Chris Waghorn I MV M
Launch Diagnostics is a leading supplier of diagnostic solutions for many pathology disciplines. Launch partners with world leading manufacturers, supplying high quality diagnostic reagents, instrumentation, and services to pathology departments across the public & private sector throughout the UK, Ireland (ACCUSAY Diagnostics) and Europe.
Key instruments for Microbiology and Virology include the AIX automated RPR instrument and the VirCLIA lotus serology platform. Our product repertoire includes serology, molecular, rd party QC and extensive AMR solutions, providing a single-supplier solution for your microbiology and virology service.
To discuss our instruments and products, visit our website www.launchdiagnostics.com
T:
E: support.uk@leicabiosystems.com
W: www.leicabiosystems.com
Key contact: Rachel Aldridge/Lily Kremer H I
Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our experts are committed to delivering Improved Quality, Integrated Solutions, and Optimized Efficiencies leading to breakthrough advances in diagnostic confidence. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture.
T:
E: uksales@lgcgroup.com
W: www.lgcstandards.com/GB/en
T:
E: sales@mast-group.com
W: www.mast-group.com
Key contact: Rachel Shelmerdine MV MG
A manufacturer and global supplier of in vitro diagnostic products. Mast is a pioneer of antibiotic susceptibility testing (AST), and has over years’ experience in this field, supporting the AMR challenge by continually updating its portfolio of AST and AMR products. Another core product is the widely established MAST URI®SYSTEM, which streamlines and optimises urine microbiology. Mast offers a range of Molecular diagnostic solutions and supplies OC-Sensor™ - the world leading solution for quantitative Faecal Immunochemical Testing (FIT).
T:
E: uk-info@novabio.com
W: www.novabiomedical.com
A world leader in point-of-care and critical care IVD. Stat Profile Prime Plus® critical care blood gas analyser features a -test menu including iMg, Creatinine, ePV and Co-oximetry. StatStrip® Glucose/Ketone provides lab-accurate measurements while eliminating interferences. StatStrip® Lactate/Hb/Hct offers screening and monitoring of sepsis or an alternative to fetal scalp pH testing; the Hb/Hct strip provides rapid anaemia assessment. StatSensor® Creatinine measures capillary whole blood creatinine and calculated eGFR for assessment of renal function prior to contrast media in radiology.
T:
E: sales@oxfordbiosystems.com
W: www.oxfordbiosystems.com
Key contact: Fiona Alcock HT MV
T:
E: uksupport@pro-lab.com
W: www.pro-lab.co.uk
T:
E: ukcustserve@promega.com
W: www.promega.co.uk
T: + ()
E: uk@sakura.eu
W: www.sakura.e
Key contact: Wesley Gater H
When it comes to diagnosing cancer, there’s no time to wait. Sakura is driven by our desire to advance cancer diagnosis through fully automated anatomic pathology. From our expertise with the first-ever Japanese microscope in , to being the original manufacturer of Tissue-Tek® technology for key pathology processes. Since , by having Tissue-Tek Genie®in our portfolio, we also provide solutions in immunohistochemistry (IHC). Visit us to learn how you best setup your lab for digital pathology.
T:
E: info@surescreen.com
W: www.surescreen.com CC
For over years, we’ve been providing bespoke solutions for organisations. SureScreen Diagnostics is an award-winning business providing quality rapid diagnostic equipment. We provide industry-leading health diagnostic and drug screening products across the UK, Europe and rest of world that allow for fast, cost-effective, accurate results to meet and exceed customers’ expectations at a fair price. With its global reach, SureScreen Diagnostics has produced and manufactured lateral flow tests for Mpox and the first dual Influenza + Covid test to be approved for use in the UK.
T:
E: peter.nest@sussexbiologicals.co.uk
W: www.sussexbiologicals.co.uk
Key contact:` Peter Nest
HT MV
Sussex Biologicals is a manufacturer of IVD solutions for use in transfusion and transplant laboratories. The company also develops and supports Bank Manager, BT LIMS system, and POC-net connectivity for POCT. The company is exclusive distributor for Inno-Train GmbH, supplying PCR and NGS based tests for RBC and HLA typing. SBL is the exclusive distributor Llusern Scientific for the Lodestar POCT analyser which offers DNA based identification of the most common bacterial pathogens in urine in only minutes.
T:
E: customercare-us@qiagen.com
W: www.qiagen.com
MV MG
T:
E: info@quadratech.co.uk
W: www.quadratech.co.uk
Key contact: Graham Jones HT
T: +
E: QONorthernEurope@quidelortho.com
W: www.quidelortho.com
CC HT
Ranked among the world’s largest in-vitro diagnostics (IVD) providers, with more than years of collective experience, we combine industry-leading expertise in immunoassay and molecular testing with a global footprint in clinical labs and transfusion medicine.
Our company’s comprehensive product portfolio delivers accuracy, speed, automation and access, providing critical information when it is needed most. Inspired by a spirit of service, the QuidelOrtho family is committed to enhancing the wellbeing of people worldwide.
T:
E: sales@radiometer.co.uk
W: www.radiometer.co.uk
Key contact: Andrew Masters
T:
E: marketing@randox.com
W: www.randox.com
CC MV
For years, Randox has developed an expertise in diagnostics and fielded a portfolio of revolutionary solutions in our commitment to improve health globally, including open-channel reagents in addition to chemistry, immunoassay and POC analysers. Our trusted market-leading quality-control includes daily QC, calibration verification and proficiency testing. Randox’s unique multiplex Biochip technology has disrupted the in-vitro diagnostic market, offering clinical, research and molecular panels. Randox products are designed to improve and streamline processes of laboratories of all sizes and requirements.
T:
E: burgesshill.marketing@roche.com
W: www.diagnostics.roche.com
CC C
As a world leader in providing technologically advanced acute care solutions at the point-of-care, Radiometer’s mission is to help caregivers make diagnostic decisions that save lives, improve patient care and optimise patient flow.
Our products include Blood gas analysis, measuring creatinine and urea from a single sample needing only μl of blood with results ready in seconds. Blood gas syringes, Immunoassay testing, Haemoglobin testing, IT and Data Management and Remote support.
CC MG
At Roche Diagnostics we believe time is precious and we are dedicated to providing diagnostic tests and services that give people more time with their loved ones. We are proud to be the UK’s leading provider of in vitro diagnostics tests and in more than million Roche diagnostic tests were used by clinicians across the UK to confirm, rule out or manage health conditions including cancer, heart disease, diabetes, COVID-, hepatitis, human papillomavirus (HPV) and many others
T:
E: info@sebia.co.uk
W: www.sebia.com/en-UK
Key contact: Kayleigh Kirk HT I
T: + ()
E: info@serosep.com
W: www.serosep.com
Key contact: Nathan Reading I MV
Serosep specialise in the manufacture and distribution of high-performance diagnostic solutions. Among our innovations is EntericBio, a versatile molecular enteric testing platform capable of swiftly detecting and identifying a spectrum of GI pathogens - Bacteria, Parasites and Viruses - within a single workflow, delivering results in just hours. Moreover, over the past years, Serosep has fostered vital distribution partnerships with esteemed entities such as Axonlab, Bio-Rad, Alifax, Thermofisher Scientific and Dynex.
T:
E: info@shimadzu.co.uk
W: www.shimadzu.co.uk
Key contact: Patty Pan CC
Shimadzu is one of the largest global providers of analytical instrumentation, responding to customers’ requirements by offering world-class technologies since .
Shimadzu’s complete portfolio covers gas and liquid chromatography as well as mass spectrometry and spectroscopy including IVDR LCMS instrumentation. In addition, Shimadzu provides reagent kits. Shimadzu innovation continues to provide state-of-the-art technologies and new solutions to simplify your workflows such as the CLAM-, a fully automated sample preparation module for seamless integration with LCMS.
T:
E: customercare.gb@siemens-healthineers.com
W: www.healthcare.siemens.co.uk
STAGO UK LTD
T:
E: stago-uk@stago.com
W: www.stago-uk.com
SYSMEX UK LTD
E: sales@sysmex.co.uk
W: www.sysmex.co.uk
Key contact: Andy Foster
TECHNIDATA UK
T:
E: uk@technidata-web.com
W: www.technidata-web.com/en-gb
THERMO FISHER DIAGNOSTICS
T:
E: tenders.tfdl@thermofisher.com
W: www.thermo.com
Key contact: Helen Johnstone C H
TOSOH BIOSCIENCE LTD
T:
E: info.diag.uk@tosoh.com
W: www.diagnostics.eu.tosohbioscience.com
Key contact: Stephanie Shaw CC HT
T:
E: enquiries@unahealth.co.uk
W: www.unahealth.co.uk
CC HT
Una Health Ltd is a leading UK provider of diagnostics for the laboratory and point of care. Founded in , we are an independent company with one key aim – to reshape the patient journey and improve overall healthcare. We believe that better healthcare is about harnessing existing technology to elevate outcomes as well as utilising cutting-edge, innovative diagnostics. We supply specialist, innovative and appropriate healthcare solutions, backed by a team with exceptional levels of experience, knowledge and support.
Our comprehensive solutions span various healthcare areas, including Community Care, Diabetes Management, Cardiovascular, Oncology, Paediatrics, Respiratory, Urinalysis, AMR and laboratory diagnostics.
T:
E: info@vhbio.com
W: www.vhbio.com
Key contact: James Briggs I MV
VH Bio Ltd, a leading UK & Republic of Ireland supplier for the life sciences industry, specialises in Transplant Diagnostics, Molecular Biology and Immunology. Committed to excellence, VH Bio focuses on delivering innovative products, employing knowledgeable scientists, and maintaining a strong quality management system with ISO accreditations. The company values environmental and social responsibility, offers a wide product range and emphasises customer satisfaction through expert consultation, training, and comprehensive after-sales support.
Key contact: Richard Hames
T:
E: sales.uk@werfen.com
W: www.werfen.co.uk
T: + (Option )
E: sales@woodleyequipment.com
W: www.woodleyequipment.com
Key contact: Customer Services
T:
E: enquiries@menarinidiag.co.uk
W: www.menarinidiag.co.uk
Key contact: Mira Pasanen CC H HT MV MG
KEY
CC Clinical chemistry
C Cytopathology
HT Haemotology & transfusion science
H Histopathology
I Immunology
MV Microbiology & virology
MG
A.Menarini Diagnostics is committed to bringing innovative solutions to the clinical diagnostics market, providing healthcare professionals with the best possible solutions for their diagnostics needs and to improve patients’ quality of life. We address laboratory needs for infectious diseases, diabetes management, urinanalysis and haematology. We offer solutions for different laboratories such as biochemistry, microbiology, molecular, point of care and histopathology. In addition, we offer innovative tube labelling solutions for pre-analytics.
T:
E: info@abscientific.com
W: www.abscientific.com
Key contact: Nigel Baron
T: +
E: ukcustomerservices@aesku.com
W: www.Aesku.com
Key contact: Anthony Celli
AGILENT TECHNOLOGIES LDA UK LIMITED
T:
E: customercare_uk@agilent.com
W: www.agilent.com
ALPHA LABORATORIES LTD
T:
E: marketing@alphalabs.co.uk
W: www.alphalabs.co.uk
Key contact: Carole Staniford
T:
E: contact@alsachim.com
W: www.alsachim.com
Key contact: Sibylle Collard
T:
E: enquiries@atomscientific.com
W: www.atomscientific.com
Key contact: Yvonne Black
Your Diagnostic IVDR Partner for Stains and Reagents for Life Sciences.
Atom Scientific manufacture an extensive range of high quality ISO Compliant and Pre-Validated Stains, Stain Kits and Reagents designed and manufactured to deliver improved and consistent diagnostic tools to fit the busy, modern Life Science Laboratory.
Supporting our specialist products Atom offers a comprehensive range of High Purity Chemicals to meet all applications of the modern day laboratory.
T:
E: BDdiagnosticsUKI@bd.com
W: www.bd.com/en-uk
MV MG
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com
T:
E: infouk@beckman.com
W: www.beckmancoulter.com
Key contact: Sue Crowe
T:
E: Contact_NorthEurope@bio-rad.com
W: www.bio-rad.com
BIOCONNECTIONS
T:
E: welcome@bioconnections.co.uk
W: www.bioconnections.co.uk
Key contact: Andrew Wood
CC HT
MV MG
BioConnections is a leading distributor in the UK, specialising in diagnostic testing solutions for clinical microbiology. We are committed to empowering healthcare professionals with reliable solutions that facilitate accurate diagnosis and effective patient care.
Our portfolio includes a wide range of diagnostic reagents and reliable instruments including:
Carbapenemase Identification and Detection Kits
Chromogenic Culture Media
Faecal Parasite Concentrator Kits
IVD Quality Control Reagents
LAMP and Lateral Flow Assays
Susceptibility Testing by BMD
Typing Sera for Salmonella, Shigella, and E. coli
T:
E: info@cellpath.com
W: www.cellpath.com
Key contact: Stacey Rogers H
T:
E: sales@cepheideurope.co.uk
W: www.cepheid.com
Key contact: Edward Levitt MV
T: +
E: customercare@copangroup.com
W: www.copangroup.com
Key contact: Alessia Tomasi MV MG
Copan is dedicated to developing high-quality sample collection products for infectious diseases, human genomics, and forensic applications, along with automated workflow solutions. Our ideas drove years of preanalytics progress, resulting in meaningful products tailored to fit any need. Among them, FLOQ technology revolutionized sample collection, while WASPLab® advanced hardware and A.I. modules redefined full lab automation. Copan’s Workflow-Integrated System Environment can accompany biological samples from the collection to impeccable diagnostics, unlocking your lab’s real potential and improving patient care.
T:
E: info@diaceutics.com
W: www.diaceutics.com
T:
E: health@thedx.co.uk
W: www.dxdelivery.com
Key contact: Jonathan Ramsey
T:
E: sales@elitechuk.com
W: www.elitechgroup.com
Key contact: Lee Roberts
T: + ()
E: sales@eurobio-scientific.co.uk
W: www.eurobio-scientific.co.uk
Key contact: Rob Cordingley HT MG
Eurobio Scientific is a manufacturer and distributor of reagents, controls, calibrators, and instrumentation in the fields of Blood Sciences, Molecular Biology, Life Sciences and Transplantation to Clinical Diagnostic and Research Laboratories.
Eurobio Scientific also operates its online, independent PathQAS Quality Assurance Schemes to help customers comply with ISO :
Product Listing
Haemostasis & Biochemistry - reagents and instruments
Molecular - Extraction and PCR Kits
Immunology QC - Allergy, Autoimmunity
Calprotectin QC
FungiLine
Bone and Cartilage Markers
Diabetes and Obesity Markers
Transplantation
T:
E: info@euroimmun.co.uk
W: www.euroimmun.co.uk
Key contact: Lee Craddock I MV
T:
E: louise.barlow@fujifilm.com
W: www.fujimed.co.uk
Key contact: Louise Barlow CC MV
T: + ()
E: EMEA@geneticsignatures.com
W: www.geneticsignatures.com/EU
Key contact: John Buckels MV
Genetic Signatures specialise in syndromic testing of infectious diseases.
Our proprietary base™ technology, reduces the genetic complexity of target pathogens and enables uniform sample processing across specimen types.
Our EasyScreen™ assays automated end-to-end workflow reduces operator intervention, PCR specific and sensitive detection of multiple pathogens in a single sample for up to samples in .hrs.
Genetic Signatures unique syndromic solutions can help your lab to improve diagnostic workflow and efficiencies, reduce costs, and improve patient management and disease surveillance.
GENTA ENVIRONMENTAL LTD
T:
E: info@gentamedical.co.uk
W: www.gentamedical.co.uk
Key contact: Carol Johnson, Claire Redpath
GREINER BIO-ONE LTD
T:
E: info@uk.gbo.com
W: www.gbo.com
Key contact: Nick Rudge HT I
GRIFOLS UK LIMITED
T:
E: ukdiagnostic@grifols.com
W: www.grifols.com
Key contact: Pat Lynch
HORIBA UK LIMITED
T:
E: sales.hduk@horiba.com
W: www.horiba.com/uk
Key contact: Tariq Neiman CC HT
T: + ()
E: uk-sales@immucor.com
W: www.immucor.com
Key contact: Patrick Lynch
Immucor is a global leader of transfusion and transplantation diagnostics. For transfusions, Immucor offers the broadest line of serological products, NEO Iris® and Echo Lumena® including traditional and unique specialty reagents, Capture® technology, and scalable solutions for automating immunohaematology testing. Our BioArray molecular immunohaematology assays provide state-of-the-art technology for pre-transfusion compatibility testing. For transplants, our LIFECODES products and MIA FORA deliver highly accurate testing solutions for donor-patient compatibility. Finally, our specialty diagnostic solutions for platelet testing and haemostasis provide important diagnostic information for today’s modern laboratories.
T:
E: enquiries@launchdiagnostics.com
W: www.launchdiagnostics.com
Key contact: Chris Waghorn
I MV M
Launch Diagnostics is a leading supplier of diagnostic solutions for many pathology disciplines. Launch partners with world leading manufacturers, supplying high quality diagnostic reagents, instrumentation, and services to pathology departments across the public & private sector throughout the UK, Ireland (ACCUSAY Diagnostics) and Europe.
Key instruments for Microbiology and Virology include the AIX automated RPR instrument and the VirCLIA lotus serology platform. Our product repertoire includes serology, molecular, rd party QC and extensive AMR solutions, providing a single-supplier solution for your microbiology and virology service.
To discuss our instruments and products, visit our website www.launchdiagnostics.com.
T:
E: support.uk@leicabiosystems.com
W: www.leicabiosystems.com
Key contact: Rachel Aldridge/Lily Kremer H I
Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our experts are committed to delivering Improved Quality, Integrated Solutions, and Optimized Efficiencies leading to breakthrough
advances in diagnostic confidence. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture.
T:
E: sales@mast-group.com
W: www.mast-group.com
Key contact: Rachel Shelmerdine MV MG
A manufacturer and global supplier of in vitro diagnostic products. Mast is a pioneer of antibiotic susceptibility testing (AST), and has over years’ experience in this field, supporting the AMR challenge by continually updating its portfolio of AST and AMR products. Another core product is the widely established MAST URI®SYSTEM, which streamlines and optimises urine microbiology. Mast offers a range of Molecular diagnostic solutions and supplies OC-Sensor™ - the world leading solution for quantitative Faecal Immunochemical Testing (FIT).
T:
E: info@mwe.co.uk
W: www.mwe.co.uk
Key contact: Lucy Pulman MV MG
Medical Wire & Equipment Co. (Bath) Ltd has been at the forefront of laboratory sciences and developing pre-analytical medical devices for over years. Our innovation is led by finding solutions to our customers challenges. MWE manufactures a wide range of products such as swabs and specimen collection media for the safe handling, collection and transportation of viruses, bacteria, and other microorganisms. Contact us to find out how we can support you.
NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL (NIBSC)
E: business@nibsc.org
W: www.nibsc.org
Key contact: Faraz Farooqi
OXFORD BIOSYSTEMS LTD
T:
E: sales@oxfordbiosystems.com
W: www.oxfordbiosystems.com
Key contact: Fiona Alcock HT MV
PROMEGA UK LTD
T:
E: ukcustserve@promega.com
W: www.promega.co.uk MG
Promega UK Ltd supplies clinical research and diagnostic laboratories with a wide range of reagent kits and instruments for the following applications: nucleic acid extraction (both manual and automated), nucleic acid quantitation, PCR amplification (including end point and qPCR), chimerism analysis, microsatellite instability (MSI) diagnosis and next generation sequencing. Promega also supplies custom reagents in the above application areas to manufacturers of diagnostic kits.
VECTOR LABORATORIES LTD
T:
E: vector@vectorlabs.co.uk
W: www.vectorlabs.com
Key contact : Dr Ann M Brighty
T:
E: customercare-us@qiagen.com
W: www.qiagen.com MV MG
T:
E: info@quadratech.co.uk
W: www.quadratech.co.uk
Key contact: Graham Jones HT
RADIOMETER LIMITED
T:
E: sales@radiometer.co.uk
W: www.radiometer.co.uk CC C
Key contact: Andrew Masters
As a world leader in providing technologically advanced acute care solutions at the point-of-care, Radiometer’s mission is to help caregivers make diagnostic decisions that save lives, improve patient care and optimise patient flow.
Our products include Blood gas analysis, measuring creatinine and urea from a single sample needing only μl of blood with results ready in seconds. Blood gas syringes, Immunoassay testing, Haemoglobin testing, IT and Data Management and Remote support.
WERFEN LTD
T:
E: sales.uk@werfen.com
W: www.werfen.co.uk
Key contact: Richard Hames HT I
R-BIOPHARM
T: + ()
E: info@r-biopharm.de
W: www.r-biopharm.com
ROCHE DIAGNOSTICS
T:
E: burgesshill.marketing@roche.com
W: www.diagnostics.roche.com
CC MG
At Roche Diagnostics we believe time is precious and we are dedicated to providing diagnostic tests and services that give people more time with their loved ones. We are proud to be the UK’s leading provider of in vitro diagnostics tests and in more than million Roche diagnostic tests were used by clinicians across the UK to confirm, rule out or manage health conditions including cancer, heart disease, diabetes, COVID-, hepatitis, human papillomavirus (HPV) and many others .
Data on le
Business Intelligence Team at Roche Diagnostics
SCHEBO BIOTECH UK LIMITED
T:
E: info@schebo.co.uk
W: www.schebo.co.uk
Key contact: Ivor Smith
SCILABWARE LTD
T:
E: enquiries@scilabware.com
W: www.scilabware.com
SEBIA
T:
E: info@sebia.co.uk
W: www.sebia.com/en-UK
T: + ()
E: info@serosep.com
W: www.serosep.com
Key contact: Nathan Reading I MV
Serosep specialise in the manufacture and distribution of high-performance diagnostic solutions. Among our innovations is EntericBio, a versatile molecular enteric testing platform capable of swiftly detecting and identifying a spectrum of GI pathogens - Bacteria, Parasites and Viruses - within a single workflow, delivering results in just hours. Moreover, over the past years, Serosep has fostered vital distribution partnerships with esteemed entities such as Axonlab, Bio-Rad, Alifax, Thermofisher Scientific and Dynex.
CC I
CC C
Key contact: Chris Plows HT I
T:
E: info@shimadzu.co.uk
W: www.shimadzu.co.uk
Key contact: Patty Pan CC
Shimadzu is one of the largest global providers of analytical instrumentation, responding to customers’ requirements by offering world-class technologies since Shimadzu’s complete portfolio covers gas and liquid chromatography as well as mass spectrometry and spectroscopy including IVDR LCMS instrumentation. In addition, Shimadzu provides reagent kits. Shimadzu innovation continues to provide state-of-the-art technologies and new solutions to simplify your workflows such as the CLAM-, a fully automated sample preparation module for seamless integration with LCMS. CC
SYSMEX UK LTD
T:
E: sales@sysmex.co.uk
W: www.sysmex.co.uk
Key contact: Andy Foster
TCS BIOSCIENCE LTD
T:
E: sales@tcsgroup.co.uk
W: www.tcsbiosciences.co.uk
Key contact: Lesley Ayres HT MV
TECHNOPATH DISTRIBUTION LTD
T: +
E: info@techno-path.com
W: www.techno-path.com
Key contact: Des Joyce
THE BINDING SITE GROUP LTD
T:
E: info@bindingsite.co.uk
W: www.bindingsite.com/en
THERMO FISHER DIAGNOSTICS
T:
E: tenders.tfdl@thermofisher.com
W: www.thermo.com
Key contact: Helen Johnstone
T:
E: info.diag.uk@tosoh.com
W: www.diagnostics.eu.tosohbioscience.com
Key contact: Stephanie Shaw
CC HT
T:
E: enquiries@unahealth.co.uk
W: www.unahealth.co.uk
CC MV
Una Health Ltd is a leading UK provider of diagnostics for the laboratory and point of care. Founded in , we are an independent company with one key aim – to reshape the patient journey and improve overall healthcare. We believe that better healthcare is about harnessing existing technology to elevate outcomes as well as utilising cutting-edge, innovative diagnostics. We supply specialist, innovative and appropriate healthcare solutions, backed by a team with exceptional levels of experience, knowledge and support.
Our comprehensive solutions span various healthcare areas, including Community Care, Diabetes Management, Cardiovascular, Oncology, Paediatrics, Respiratory, Urinalysis, AMR and laboratory diagnostics
T:
E: info@vhbio.com
W: www.vhbio.com
Key Contact: James Briggs I MV
VH Bio Ltd, a leading UK & Republic of Ireland supplier for the life sciences industry, specialises in Transplant Diagnostics, Molecular Biology and Immunology. Committed to excellence, VH Bio focuses on delivering innovative products, employing knowledgeable scientists, and maintaining a strong quality management system with ISO accreditations. The company values environmental and social responsibility, offers a wide product range and emphasises customer satisfaction through expert consultation, training, and comprehensive after-sales support.
KEY
CC Clinical chemistry
C Cytopathology
HT Haemotology & transfusion science
H Histopathology
I Immunology
MV Microbiology & virology
MG Molecular pathology & genomics
T:
E: enquiries@menarinidiag.co.uk
W: www.menarinidiag.co.uk CC
Menarini Diagnostics is active in the fields of HbAc, histopathology, autoimmunity, infectious diseases, haemoglobinopathy and molecular pathology. With a historically strong presence in the HbAc and urine sediment markets, the company has more recently expanded to offer a Total Tissue DiagnosticsTM solution in histology, the innovative Zenit Pro for autoimmunity, and a range of both point of care and laboratory infectious disease systems. Menarini is committed to innovation, with a constant stream of leading-edge products in the development pipeline.
T:
E: info@cirdan.com
W: www.cirdan.com
Key contact: Rebecca Fitton H
Cirdan is a leading provider of pathology informatics and imaging solutions that support and speed up patient diagnosis. Cirdan is recognised as one of the leading suppliers of laboratory information systems (LIS) worldwide. Our products include ULTRA, a LIS that supports and streamlines clinical laboratory operations, specimen x-ray cabinets which expedite breast cancer diagnosis and Tutor, a digital pathology education platform. With additional solutions that support artificial intelligence and machine learning in digital pathology technologies. Find out more at www.cirdan.com.
T:
E: info@euroimmun.co.uk
W: www.euroimmun.co.uk
Key contact: Lee Craddock I MV
T:
E: info@uk.gbo.com
W: www.gbo.com
Key contact: Nick Rudge HT I
T:
E: sales@gtvision.co.uk
W: www.gtvision.co.uk
Key contact: Neil Patterson H MV
Established + years, GT Vision Ltd. is a specialist UK-owned microscope company with a wealth of experience and knowledge in microscope sales, installation, training, service and repair.
We are main agents for Leica microscopes and other firmly established brands, and additionally offer our own extensive and more affordable range of microscopes, accessories, cameras and scanning systems.
Our dedicated service and support department offers repairs, plus routine and contract service for almost any make, model and age of microscope.
T: + ()
E: raldridge@illumina.com
W: https://emea.illumina.com
Key contact: Rachel Aldridge/Lily Kremer MV MG
Our mission is to improve human health by unlocking the power of the genome. We believe that, together, we can use genomics to build a stronger world for all.
T:
E: industrial@olympus.co.uk
W: www.Olympus-lifescience.com
Key contact: Paul Roberts
T:
E: discover.uk@nikon.com
W: www.nikon.co.uk/en_GB
Key contact: Natalia Alexander H MV
Nikon are focused on serving customers in the clinical microscopy field with industry leading solutions. To meet the demands of clinical laboratory specialists and researchers, Nikon provides ergonomic, flexible microscopes with enhanced functionality and ease of use. Our microscopes are designed to ensure a natural posture is maintained while in use, and our camera systems offer high resolution images that can be easily streamed for the evolving needs of our clinical customers.
T:
E: slsinfo@scientific-labs.com.
W: www.scientificlabs.co.uk
Key contact: Sandie Flanagan H MV
T:
E: vector@vectorlabs.co.uk
W: www.vectorlabs.com
Key contact: Dr Ann M Brighty C H
T:
E: paulc@woodleyequipment.com
W: www.woodleyequipment.com
Key contact: Customer Services CC HT
T:
E: customercare.uk@zeiss.com
W: www.zeiss.co.uk
Key contact: ZEISS Customer Care
CC Clinical chemistry
C Cytopathology
HT Haemotology & transfusion science
H Histopathology
I Immunology
MV Microbiology & virology
MG Molecular pathology & genomics
AB SCIENTIFIC LTD
T:
E: info@abscientific.com
W: www.abscientific.com
Key contact: Nigel Baron
T:
E: welcome@bioconnections.co.uk
W: www.bioconnections.co.uk
Key contact: Andrew Wood MV MG
BioConnections is a leading distributor in the UK, specialising in diagnostic testing solutions for clinical microbiology. We are committed to empowering healthcare professionals with reliable solutions that facilitate accurate diagnosis and effective patient care.
Our portfolio includes a wide range of diagnostic reagents and reliable instruments including:
Carbapenemase Identification and Detection Kits
Chromogenic Culture Media
Faecal Parasite Concentrator Kits
IVD Quality Control Reagents
LAMP and Lateral Flow Assays
Susceptibility Testing by BMD
Typing Sera for Salmonella, Shigella, and E. coli
T:
E: info@diaceutics.com
W: www.diaceutics.com
T:
E: sales@dwscientific.co.uk
W: www.dwscientific.com
Key contact: Steve Robertson
MONMOUTH SCIENTIFIC LIMITED
T:
E: info@monmouthscientific.co.uk
W: www.monmouthscientific.co.uk
Key contact: Lewis Irish CC MV
NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL (NIBSC)
E: business@nibsc.org
W: www.nibsc.org
Key contact: Faraz Farooqi
T:
E: info@pathwaydiagnostics.com
W: www.pathwaydiagnostics.com
T:
E: marketing@randox.com
W: www.randox.com
CC MV
For years, Randox has developed an expertise in diagnostics and fielded a portfolio of revolutionary solutions in our commitment to improve health globally, including open-channel reagents in addition to chemistry, immunoassay and POC analysers. Our trusted market-leading quality-control includes daily QC, calibration verification and proficiency testing. Randox’s unique multiplex Biochip technology has disrupted the in-vitro diagnostic market, offering clinical, research and molecular panels. Randox products are designed to improve and streamline processes of laboratories of all sizes and requirements.
T: + ()
E: info@r-biopharm.de
W: www.r-biopharm.com
TCS BIOSCIENCE LTD
T:
E: sales@tcsgroup.co.uk
W: www.tcsbiosciences.co.uk
Key contact: Lesley Ayres
TECHNOPATH DISTRIBUTION LTD
T: +
E: info@techno-path.com
W: www.techno-path.com
Key contact: Des Joyce
T:
W: www.veoliawatertechnologies.co.uk
CC I
KEY
CC Clinical chemistry
C Cytopathology
HT Haemotology & transfusion science
H Histopathology
I Immunology
MV Microbiology & virology
MG Molecular pathology & genomics
AB SCIENTIFIC LIMITED
T:
E: info@abscientific.com
W: www.abscientific.com
Key contact: Nigel Baron
ALPHA LABORATORIES LTD
T:
E: marketing@alphalabs.co.uk
W: www.alphalabs.co.uk
Key contact: Carole Staniford
ATOM SCIENTIFIC LTD
T:
E: enquiries@atomscientific.com
W: www.atomscientific.com
Key contact: Yvonne Black CC MG
CELLPATH LTD
T:
E: info@cellpath.com
W: www.cellpath.com
Key contact: Stacey Rogers H
DON WHITLEY SCIENTIFIC LIMITED
T:
E: sales@dwscientific.co.uk
W: www.dwscientific.co.uk
Key contact: Steve Robertson MV
DX GROUP
T:
E: health@thedx.co.uk
W: www.dxdelivery.com
Key contact: Jonathan Ramsey
ELKAY LABORATORY PRODUCTS (UK) LTD
T:
E: sales@elkaylabs.com
W: www.elkaylabs.com
Key contact: Robin Conway CC MG
GENTA ENVIRONMENTAL LTD
T:
E: info@gentamedical.co.uk
W: www.gentamedical.co.uk
Key contact: Carol Johnson, Claire Redpath
T:
E: customersupport-uk@gilson.com
W: www.gilson.com
Key contact: Dave Rooks CC MV
We are Gilson, a third-generation family-owned company developing liquid handling, purification and extraction solutions for the life science industry. Since , we have developed innovative products, designed to improve the reproducibility and traceability of data, connecting with the scientific community to help researchers achieve verifiable results. Since the introduction of the high-precision PIPETMAN® pipette, Gilson has revolutionised laboratories, providing a range of quality and innovative solutions including purification systems, solid phase extraction (SPE) systems, automated liquid handlers, pipettes & accessories.
MWE (MEDICAL WIRE & EQUIPMENT CO. ) LTD.
T:
E: info@mwe.co.uk
W: www.mwe.co.uk
Key contact: Lucy Pulman MV MG
Medical Wire & Equipment Co. (Bath) Ltd has been at the forefront of laboratory sciences and developing pre-analytical medical devices for over years. Our innovation is led by finding solutions to our customers challenges. MWE manufactures a wide range of products such as swabs and specimen collection media for the safe handling, collection and transportation of viruses, bacteria, and other microorganisms. Contact us to find out how we can support you.
METTLER TOLDEO LIMITED
T:
E: enquire.mtuk@mt.com
W: www.mt.com
MONMOUTH SCIENTIFIC LIMITED
T:
E: info@monmouthscientific.co.uk
W: www.monmouthscientific.co.uk
Key contact: Lewis Irish
OLYMPUS
T:
E: industrial@olympus.co.uk
W: www.Olympus-lifescience.com
Key contact: Paul Roberts
PFMMEDICAL UK
T:
E: uk@pfmmedical.com
W: www.pfmmedical.co.uk/products/ histotechnology/
Key contact: Jemma Heath
SAKURA FINETEK UK LTD
T: + ()
E: uk@sakura.eu
W: www.sakura.eu
Key contact: Wesley Gater
When it comes to diagnosing cancer, there’s no time to wait. Sakura is driven by our desire to advance cancer diagnosis through fully automated anatomic pathology. From our expertise with the first-ever Japanese microscope in , to being the original manufacturer of Tissue-Tek® technology for key pathology processes. Since , by having Tissue-Tek Genie®in our portfolio, we also provide solutions in immunohistochemistry (IHC). Visit us to learn how you best setup your lab for digital pathology.
SARSTEDT LIMITED
T: +
E: info@sarstedt.com
W: www.sarstedt.com/en/home
SCIENTIFIC LABORATORY SUPPLIES
T:
E: slsinfo@scientific-labs.com
W: www.scientificlabs.co.uk
Key contact: Sandie Flanagan
SCILABWARE LTD
T:
E: enquiries@scilabware.com
W: www.scilabware.com
SHIMADZU
T:
E: info@shimadzu.co.uk
W: www.shimadzu.co.uk
Key contact: Patty Pan CC
Shimadzu is one of the largest global providers of analytical instrumentation, responding to customers’ requirements by offering world-class technologies since
Shimadzu’s complete portfolio covers gas and liquid chromatography as well as mass spectrometry and spectroscopy including IVDR LCMS instrumentation. In addition, Shimadzu provides reagent kits. Shimadzu innovation continues to provide state-of-the-art technologies and new solutions to simplify your workflows such as the CLAM-, a fully automated sample preparation module for seamless integration with LCMS.
T: + ()
E: labsupplies@solmedialtd.com
W: www.solmedialtd.com H MV
At Solmedia, we have proudly supplied laboratories across the Country for over years, working closely with our clients to deliver the best products, service and customer support possible.
Our passion for support and our drive to improve laboratory performance and results allow us to help labs meet the ever-increasing demands of the industry, supplying reliable products and equipment designed to deliver consistency and compliance, as well as additional services that ensure your equipment continues to perform to the highest standards.
T:
E: uk@technidata-web.com
W: www.technidata-web.com/en-gb
T:
E: sales.ap.uk@thermo.com
W: www.thermofisher.com/pathology
Key contact: Helen Johnstone C H
T:
E: customercare.uk@zeiss.com
W: www.zeiss.co.uk
Key contact: ZEISS Customer Care H
Comprehensive Critical Care Blood Gas Analyser
•Combines blood gases, electrolytes, metabolites hematology and CO-oximetry
•Delivers a 24 test critical care profile in approximately one minute
•Unique tests for iMg, urea, creatinine, and estimated plasma volume (ePV)
With Wireless and Wired Connectivity to the LIS and EMR
Glucose/Ketone POC Testing
•No known clinical interferences
•Only glucose meter cleared by US FDA and Health Canada for critically ill patients
Simple, Fast Capillary Blood Analyser
•Glycaemic Control
•Kidney Function
•Lipids
•Coagulation
•Inflammation
Creatinine, eGFR POC Testing
•Rapid identification of AKI
Lactate, Hb/Hct POC Testing
•Rapid sepsis and anaemia screening and monitoring
•Measures both haemoglobin and haematocrit
novabiomedical.com
•STAT for renal function in imaging departments
For more information contact us at uk-info@novabio.com
At Roche we believe time is precious
We focus our energy and investment on developing tests and treatments that change lives and give us more quality time with the people we love. roche.co.uk